These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

721 related items for PubMed ID: 29871264

  • 1. [Effect of nasal glucocorticoid combined with loratadine or montelukast on allergic rhinitis].
    Jia MH, Chen XY, Zhang Y, Liao ZS.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar 05; 31(5):369-373. PubMed ID: 29871264
    [Abstract] [Full Text] [Related]

  • 2. Individualized treatment for allergic rhinitis based on key nasal clinical manifestations combined with histamine and leukotriene D4 levels.
    Shen C, Chen F, Wang H, Zhang X, Li G, Wen Z.
    Braz J Otorhinolaryngol; 2020 Mar 05; 86(1):63-73. PubMed ID: 30467056
    [Abstract] [Full Text] [Related]

  • 3. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis.
    Di Lorenzo G, Pacor ML, Pellitteri ME, Morici G, Di Gregoli A, Lo Bianco C, Ditta V, Martinelli N, Candore G, Mansueto P, Rini GB, Corrocher R, Caruso C.
    Clin Exp Allergy; 2004 Feb 05; 34(2):259-67. PubMed ID: 14987306
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of nasal corticosteroids alone or combined with antihistamines or montelukast in treatment of allergic rhinitis.
    Pinar E, Eryigit O, Oncel S, Calli C, Yilmaz O, Yuksel H.
    Auris Nasus Larynx; 2008 Mar 05; 35(1):61-6. PubMed ID: 17826020
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
    Moinuddin R, deTineo M, Maleckar B, Naclerio RM, Baroody FM.
    Ann Allergy Asthma Immunol; 2004 Jan 05; 92(1):73-9. PubMed ID: 14756468
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast.
    Ratner PH, Howland WC, Arastu R, Philpot EE, Klein KC, Baidoo CA, Faris MA, Rickard KA.
    Ann Allergy Asthma Immunol; 2003 May 05; 90(5):536-42. PubMed ID: 12775135
    [Abstract] [Full Text] [Related]

  • 8. Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis.
    Pullerits T, Praks L, Ristioja V, Lötvall J.
    J Allergy Clin Immunol; 2002 Jun 05; 109(6):949-55. PubMed ID: 12063523
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.
    Nayak AS, Philip G, Lu S, Malice MP, Reiss TF, Montelukast Fall Rhinitis Investigator Group.
    Ann Allergy Asthma Immunol; 2002 Jun 05; 88(6):592-600. PubMed ID: 12086367
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis.
    Anolik R, Mometasone Furoate Nasal Spray With Loratadine Study Group.
    Ann Allergy Asthma Immunol; 2008 Mar 05; 100(3):264-71. PubMed ID: 18426147
    [Abstract] [Full Text] [Related]

  • 12. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.
    Meltzer EO, Malmstrom K, Lu S, Prenner BM, Wei LX, Weinstein SF, Wolfe JD, Reiss TF.
    J Allergy Clin Immunol; 2000 May 05; 105(5):917-22. PubMed ID: 10808172
    [Abstract] [Full Text] [Related]

  • 13. [Allergic rhinitis management:environment control and patient education].
    Qiao Y, Liu T, Zhang KJ, Feng Y, Liu Y, Li KT.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Sep 05; 31(17):1315-1321. PubMed ID: 29798221
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Meta-analysis of leukotriene receptor antagonist montelukast in the treatment of allergic rhinitis].
    Lu Y, Yin M, Cheng L.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Aug 05; 49(8):659-67. PubMed ID: 25351124
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of fixed-dose loratadine/montelukast in seasonal allergic rhinitis: effects on nasal congestion.
    Prenner B, Anolik R, Danzig M, Yao R.
    Allergy Asthma Proc; 2009 Aug 05; 30(3):263-9. PubMed ID: 19549427
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of prophylactic treatment with montelukast and montelukast plus add-on loratadine for seasonal allergic rhinitis.
    Yamamoto H, Yamada T, Sakashita M, Kubo S, Susuki D, Tokunaga T, Ogi K, Terasawa Y, Yamashita S, Kayano Y, Masada M, Kimura Y, Fujieda S.
    Allergy Asthma Proc; 2012 Aug 05; 33(2):e17-22. PubMed ID: 22525385
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Montelukast as an adjuvant to mainstay therapies in patients with seasonal allergic rhinitis.
    Topuz B, Ogmen GG.
    Clin Exp Allergy; 2003 Jun 05; 33(6):823-6. PubMed ID: 12801319
    [Abstract] [Full Text] [Related]

  • 20. Quality of life assessment in patients with moderate to severe allergic rhinitis treated with montelukast and/or intranasal steroids: a randomised, double-blind, placebo-controlled study.
    Goh BS, Ismail MI, Husain S.
    J Laryngol Otol; 2014 Mar 05; 128(3):242-8. PubMed ID: 24618303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.